Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Brown

Interventional Pain Medicine Fort Collins, CO Doctor of Osteopathy

NPI 1265674279 CMS profile 1225433

3744 S Timberline Rd, Suite 102, Fort Collins, CO 80525

Open in the dashboard

General payments

$34,030

313 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Brown of Fort Collins, CO is reported in the CMS Open Payments database as having received $34,030 across 313 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,617 58
2024 General $3,683 23
2023 General $1,203 60
2022 General $6,535 87
2021 General $1,099 30
2020 General $244 7
2019 General $649 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Brown
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Michael Brown were reported at $20,617. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Michael Brown Interventional Pain Medicine median Middle half National median
2019 $649 $684 $216–$2,079 $163
2020 $244 $382 $122–$1,109 $114
2021 $1,099 $552 $167–$1,554 $132
2022 $6,535 $605 $187–$1,924 $149
2023 $1,203 $671 $195–$1,915 $160
2024 $3,683 $684 $206–$1,837 $164
2025 $20,617 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $24,513 117 payments
  2. Medtronic, Inc. $4,488 112 payments
  3. Painteq LLC $2,866 21 payments
  4. Relievant Medsystems, Inc. $1,040 10 payments
  5. SI-BONE, Inc. $275 5 payments
  6. Medtronic USA, Inc. $259 22 payments
  7. Vertos Medical, Inc. $138 2 payments
  8. TerSera Therapeutics LLC $128 7 payments
  9. Boston Scientific Corporation $71 3 payments
  10. Saol Therapeutics Inc. $41 1 payment
  11. Other $211 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $13,250 5 payments
  2. Travel and Lodging $8,404 32 payments
  3. Food and Beverage $7,855 270 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,850 3 payments
  5. Consulting Fee $940 1 payment
  6. Education $731 2 payments
Products named General payments · program years 2019–2025
  1. PROCLAIM Structural Heart $16,612 14 payments
  2. PROCLAIM Neuromodulation $3,256 18 payments
  3. PROCLAIM Structural Heart $3,255 15 payments
  4. PAINTEQ $2,866 21 payments
  5. VANTA ADAPTIVESTIM $1,808 10 payments
  6. INTELLIS ADAPTIVESTIM $1,524 55 payments
  7. Intracept Pain $1,040 10 payments
  8. Intracept Pain $887 9 payments
  9. ETERNA $481 9 payments
  10. SYNCHROMEDII $345 8 payments
  11. Other $3,203 158 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

39

Median for Anesthesiology: 322

Drug cost

$245

Median for Anesthesiology: $8,738

Branded share of claims

64.1%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 25 $178
Oxycodone Hcl Generic 14 $67

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$276,295

Of which drugs: $1,373

Medicare patients

553

Average age 73

Services billed

5,070

329 women, 224 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Depression 30%
Ischemic heart disease 27%
Chronic kidney disease 24%
Diabetes 20%
Osteoporosis 20%
COPD 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 100 775 $610
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 67 962 $87
Injection, fentanyl citrate, 0.1 mg J3010 Office 61 67 $49
Injection, midazolam hydrochloride, per 1 mg J2250 Office 68 157 $17

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

313 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record